Fanconi anemia: Adult head and neck cancer and hematopoietic mosaicism

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 7, 2005, Pages 635-639

  Alter, Blanche P ^a   Joenje, Hans ^b   Oostra, Anneke B ^b   Pals, Gerard ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; CAFE AU LAIT SPOT; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME BREAKAGE; DEHYDRATION; DNA REPAIR; FANCONI ANEMIA; FEMALE; FEVER; FUNCTION TEST; HEAD AND NECK CANCER; HEARING IMPAIRMENT; HUMAN; KLIPPEL FEIL SYNDROME; MUCOSA INFLAMMATION; OVARY INSUFFICIENCY; PERIODONTAL DISEASE; PIGMENT DISORDER; SMALL CELL CARCINOMA; XEROSTOMIA;

ADULT; CARCINOMA, SQUAMOUS CELL; CHROMOSOME BREAKAGE; FANCONI ANEMIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOSAICISM;

EID: 23044466578     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.7.635     Document Type: Article

References (25)

1. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003;97:425-440.
2. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
3. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Philadelphia, Pa: WB Saunders Co; 2003:280-365.
4. Rosenberg PS, Huang Y, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood. 2004;104:350-355.
5. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822-826.
6. Kutler DI, Auerbach AD, Satagopan J, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129:106-112.
7. Lo Ten Foe JR, Kwee ML, Rooimans MA, et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet. 1997;5:137-148.
8. Bremer M, Schindler D, Gross M, Dork T, Morlot S, Karstens JH. Fanconi's anemia and clinical radiosensitivity. Strahlenther Onkol. 2003;179:748-753.
9. Alter BP. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol. 2002;62:345-347.
10. Lensch MW, Tischkowitz M, Christianson TA, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood. 2003;102:7-16.
11. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73:391-396.
12. Cervenka J, Arthur D, Yasis C. Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics. 1981;67:119-127.
13. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.
14. Joenje H, Pals G, Zwaan CM. Fanconi anemia. In: Fuchs J, Podda M, eds. Encyclopedia of Medical Genomics and Proteomics. New York, NY: Marcel Dekker Inc; 2004:447-451.
15. State Corp. Stata Statistical Software: Release 8.0. College Station, Tex: Stata Corp; 2003.
16. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
17. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.
18. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
19. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001;345:1890-1900.
20. Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus - associated malignancies. J Natl Cancer Inst. 2003;95:1648-1650.
21. Rosas SL, Koch W, Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, 06-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001;61:939-942.
22. Kutler DI, Wreesmann VB, Goberdhan A, et al. Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2003;95:1718-1721.
23. van Zeeburg HJT, Snijders PJF, Joenje H, Brakenhoff RH. Re: human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2004;96:968-969.
24. Hermsen MAJA, Xie Y, Rooimans MA, et al. Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi anemia. Fam Cancer. 2001;1:39-43.
25. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004;23:1000-1004.